口服特兰克萨姆酸的双重益处:减少梅拉斯玛严重程度和炎症
Abdullah Demirbas1, Gozde Ulutas Demirbas2, Esin Diremsizoglu1
1Kocaeli University Faculty of Medicine, Department of Dermatology, Kocaeli, Turkey.
Journal of cosmetic dermatology
|May 20, 2025
概括
口服的特兰胺酸 (TXA) 显著降低了瘤的严重程度,并调节了全身炎症. 这种治疗影响关键的炎症标志物,表明TXAA.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 黑色素是一种由荷尔蒙,紫外线暴露和炎症影响的慢性超色素性疾病.
- 作为一种常见的黑色素瘤治疗方法,口服特兰胺酸 (TXA) 的全身炎症效应尚未完全理解.
研究的目的:
- 评估口服TXA对瘤严重性的影响.
- 评估TXA治疗黑色素治疗期间系统性炎症标志物的变化.
主要方法:
- 追溯研究80名黑色素瘤患者和80名对照人群.
- 患者接受了口服特兰胺酸 (500毫克/天) 3 个月.
- 测量了梅拉斯马区域和严重性指数 (MASI) 和各种炎症标志物.
主要成果:
- 口服TXA显著降低了瘤的严重程度 (65.1%的MASI减少) 和调节了炎症标志物.
- 单细胞,中性粒细胞,MHR,MLR和NLR等关键标志物下降,而HDL和淋巴细胞水平增加.
- 中性粒细胞与淋巴细胞比率 (NLR) 和高密度胆固醇水平预测了治疗反应.
结论:
- 口服TXA有效地改善了瘤,并影响了全身炎症.
- NLR和HDL可以作为监测瘤治疗疗效的生物标志物.
- TXA的抗炎作用有助于其在黑色素瘤中的治疗效益.
相关概念视频
Combined Effects of Drugs: Synergism
6.2K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.2K
Antiasthma Drugs: Leukotriene Modifiers
2.2K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.2K
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
1.3K
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
1.3K
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
1.1K
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
1.1K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
2.3K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
2.3K
Drugs for Treatment of Ulcerative Colitis in IBD
705
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
705


